Source: VIB, Flanders Interuniversity Institute of Biotechnology
Posted: January 16, 2006
Doctors at the Catholic University of Leuven, connected with the University Hospital - Gasthuisberg, the Stem Cell Institute Leuven (SCIL), and the Flanders Interuniversity Institute for Biotechnology (VIB), recently publishing a major breakthrough in the treatment of patients with acute myocardial infarction. Their research shows that the administration of a patient's own stem cells has a significant positive effect on the heart's recovery: in the patients studied, the size of the infarct was clearly reduced. This study is a world-first − its exciting results are being published in the prominent medical journal The Lancet.
No comments:
Post a Comment